| Literature DB >> 33654947 |
Liuliu Jiang1,2, Shengyan Chen1,2, Kairui Sun1,2, Peng Zhou1,2, Xin Wei1,2.
Abstract
Candida albicans is the most common cause of fungal infections worldwide. Infection by C. albicans is closely associated with its ability to form a biofilm, closely packed communities of cells attached to the surfaces of human tissues and implanted devices, in or on the host. When tested for susceptibility to antifungals, such as polyenes, azoles, and allylamines, C. albicans cells in a biofilm are more resistant to antifungal agents than C. albicans cells in the planktonic form. Cyclic Adenosine monophosphate (cAMP) is one of the key elements for triggering hyphal and biofilm formation in C. albicans. It is hard to detect or extract molecular markers (e.g., cAMP) from C. albicans biofilms because the biofilms have a complex three-dimensional architecture with an extracellular matrix surrounding the cell walls of the cells in the biofilm. Here, we present an improved protocol that can effectively measure the level of intracellular cAMP in C. albicans biofilms.Entities:
Keywords: Biofilm; Candida albicans; Cyclic Adenosine monophosphate; Enzyme linked immunosorbent assay; Second messenger; cAMP enzyme immunoassay
Year: 2019 PMID: 33654947 PMCID: PMC7853961 DOI: 10.21769/BioProtoc.3461
Source DB: PubMed Journal: Bio Protoc ISSN: 2331-8325